about
Efficacy and Safety Profile of Diclofenac/Cyclodextrin and Progesterone/Cyclodextrin Formulations: A Review of the Literature DataSupramolecular Complexation of Carbohydrates for the Bioavailability Enhancement of Poorly Soluble DrugsEncapsulation of biocides by cyclodextrins: toward synergistic effects against pathogensMelarsoprol cyclodextrin inclusion complexes as promising oral candidates for the treatment of human African trypanosomiasisSusceptibility of outer hair cells to cholesterol chelator 2-hydroxypropyl-β-cyclodextrine is prestin-dependentCyclodextrins as Emerging Therapeutic Tools in the Treatment of Cholesterol-Associated Vascular and Neurodegenerative DiseasesThe Potential of Cyclodextrins as Novel Active Pharmaceutical Ingredients: A Short OverviewNanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A ReviewExploring the potential of flubendazole in filariasis control: evaluation of the systemic exposure for different pharmaceutical preparationsPharmacokinetics, efficacy, and safety evaluation of docetaxel/hydroxypropyl-sulfobutyl-β-cyclodextrin inclusion complexAffinity-Based Drug DeliveryThe unexpected increase of clotrimazole apparent solubility using randomly methylated β-cyclodextrin.Changes in the Physicochemical Properties of Piperine/β-Cyclodextrin due to the Formation of Inclusion ComplexesImprovement of water solubility and in vitro dissolution rate of aceclofenac by complexation with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.Effect of cyclodextrin complexation on the aqueous solubility and solubility/dose ratio of praziquantel.Unexpected differences between planar and column liquid chromatographic retention of 1-acenaphthenol enantiomers controlled by supramolecular interactions involving β-cyclodextrin at subambient temperatures.Superstructure based on β-CD self-assembly induced by a small guest molecule.Experimental, molecular docking investigations and bioavailability study on the inclusion complexes of finasteride and cyclodextrins.New formulation of an old drug in hypertension treatment: the sustained release of captopril from cyclodextrin nanoparticles.Click synthesis of estradiol-cyclodextrin conjugates as cell compartment selective estrogensStructure determination of fexofenadine-α-cyclodextrin complex by quantitative 2D ROESY analysis and molecular mechanics studies.A 5,7-dimethoxyflavone/hydroxypropyl-β-cyclodextrin inclusion complex with anti-butyrylcholinesterase activity.Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution.Enhanced solubilisation of six PAHs by three synthetic cyclodextrins for remediation applications: molecular modelling of the inclusion complexes.Gefitinib loaded folate decorated bovine serum albumin conjugated carboxymethyl-beta-cyclodextrin nanoparticles enhance drug delivery and attenuate autophagy in folate receptor-positive cancer cellsMultimodal CARS microscopy of structured carbohydrate biopolymers.Charge sensitivity approach to mutual polarization of reactants: molecular mechanics perspective.Methyl-β-cyclodextrins preferentially remove cholesterol from the liquid disordered phase in giant unilamellar vesiclesNanopore-based fourth-generation DNA sequencing technologyEvidence of the Disassembly of α-Cyclodextrin-octylamine Inclusion Compounds Conjugated to Gold Nanoparticles via Thermal and Photothermal Effects.Preparation and antitumor effects of glaucocalyxin A-γ-cyclodextrin clathrateDevelopment and optimization of a meloxicam/β-cyclodextrin complex for orally disintegrating tablet using statistical analysis.Cyclodextrins tethered with oligolactides - green synthesis and structural assessment.The transferrin receptor and the targeted delivery of therapeutic agents against cancer.Structural insights into the inclusion complexes between clomiphene citrate and β-cyclodextrin: The mechanism of preferential isomeric selection.Enhanced dissolution and stability of lansoprazole by cyclodextrin inclusion complexation: preparation, characterization, and molecular modelingInfluence of Ethanol as a Co-Solvent in Cyclodextrin Inclusion Complexation: A Molecular Dynamics Study.Molecular modeling-based inclusion mechanism and stability studies of doxycycline and hydroxypropyl-β-cyclodextrin complex for ophthalmic delivery.Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapyPharmacokinetic comparison of different flubendazole formulations in pigs: A further contribution to its development as a macrofilaricide molecule.
P2860
Q26768705-A407D06C-7A74-40BD-867C-65B9593D4885Q26777831-E5A70711-024C-4963-8C06-0ED75E263E54Q27010217-FA07716C-1237-4A09-BC44-324C6770498CQ27306003-7312B46E-F0B4-476E-922C-059787726346Q27342399-E032A44D-6F58-4078-A24D-AEEC0984382FQ28071254-FE34AA66-AA79-49FF-B28A-522E7691E116Q28076502-621B8BAF-7E80-4690-A8DA-CDA684D13EFCQ28394719-3A8A2554-D312-4BCF-9201-047E07C9838AQ28539170-20C0B695-05DA-4168-B301-88392595E395Q28742710-471FAE01-6B7B-4D59-AE42-27B52A5E1ECCQ29543246-A5BBBDB4-8417-4913-920D-07E146B1C7FDQ30885322-68037ABE-88BC-45F5-A6AA-189D226B2E1FQ31061194-5D782B16-1775-4401-95A4-54B76C94E449Q33463689-E9880BED-9132-4768-91AE-5038CD1E8E0AQ33563610-5A0B7724-6DB1-4ABB-9157-98E2A16D2C5BQ33607046-932E3C5E-C302-46DC-9DE7-46AB1570A33CQ33760853-C50035A7-75C6-437F-ACDF-7D208C37C995Q33803717-C320E3E9-2AB5-41B1-81B1-F74104C4203CQ33947936-35C7324E-0384-43EB-8B9E-12B181961E37Q34006085-A11C82EB-812E-462D-94BF-C667121FCF76Q34194937-76DB11F2-B7CA-4DF8-A566-8EFB9F6E4C81Q34265148-E901DA1B-09B9-4A83-9B75-EDA62A138EC9Q34284551-AA572CF3-06C9-4CAE-99AE-D8D7553AEA87Q34426933-DD7B4057-8373-478E-8CD5-62DD3298214CQ34447234-75273658-D5D3-44E7-9509-12FEB28AEE4AQ34476587-F175DC72-546B-4E27-9108-F8D97AFAE939Q34737576-1298DB31-92E0-4FCD-B7E3-CC1E3DC8BB6BQ34862443-7580114A-8CC0-4118-AEE5-F4E36D0CECE6Q35543895-33F89A90-F144-4F4D-BC51-180709923FC2Q36179124-CA4B680C-C865-4515-B796-CAA104157196Q36183655-568A42E7-B236-415D-82D0-FFD887A5CB14Q36201299-4DD61BF3-C79B-4FA9-9470-73F7DD8505B5Q36382219-0EB3AA5B-4FA0-4FD5-8E4B-2E75FDD86811Q36406637-B1C95679-D4AB-4EB2-AADD-E4358D5E5BABQ36413299-8EE229EF-EE6B-4799-921E-A680FAA3C440Q36442107-ED55579D-FF47-4531-BF8D-9010AFDAF1E1Q36504995-DB1A25D4-6362-4A58-B759-FB0E46DE20AAQ36636481-D2F761E6-7CE0-4EF6-B0BC-479DFF5CA794Q36696647-AE68B986-F707-478C-A204-E404C08409EBQ36841497-E920AA05-CD3D-4AD9-8F43-E3BD9DFC7315
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Cyclodextrins and their pharmaceutical applications.
@ast
Cyclodextrins and their pharmaceutical applications.
@en
type
label
Cyclodextrins and their pharmaceutical applications.
@ast
Cyclodextrins and their pharmaceutical applications.
@en
prefLabel
Cyclodextrins and their pharmaceutical applications.
@ast
Cyclodextrins and their pharmaceutical applications.
@en
P1476
Cyclodextrins and their pharmaceutical applications
@en
P2093
Dominique Duchêne
P356
10.1016/J.IJPHARM.2006.10.044
P407
P577
2006-11-09T00:00:00Z